Skip to main content
Premium Trial:

Request an Annual Quote

Cause Not Yet Spotted

A new study was unable to find a cause for persistent long COVID symptoms, NPR reports.

Researchers from the US National Institute of Allergy and Infectious Diseases conducted a longitudinal study of long COVID among nearly 200 people who had laboratory-confirmed COVID-19 and 120 antibody-negative controls. As they report in the Annals of Internal Medicine, the NIAID team found that just more than half of those who had COVID-19 reported symptoms consistent with post-acute sequelae of SARS-CoV-2 infection (PASC), or long COVID.

All participants underwent a series of physical examinations, laboratory testing, and questionnaires, as well as assessments of cognitive and cardiopulmonary function. A portion underwent additional immunologic and virologic analyses. But, as they report in their paper, the researchers were unable to find anything to explain PASC from these tests.

But as NPR notes, that does not mean there is nothing wrong, just that these tests could not detect it. David Putrino from Mount Sinai Hospital tells it that the study did not go in-depth enough. NPR adds that the NIAID team is planning additional studies with fancier tests and that the National Institutes of Health is enrolling with thousands of patients in a new study.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.